Procalcitonin as a marker of sepsis and outcome in patients with neurotrauma: An observation study

BMC Anesthesiology

Volumn 13, Issue , 2013, Pages

  Deng, Shuixiang ^a   Zhu, Hechen ^a   Wang, Kunlun ^b   Cao, Tongwa ^a  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Mortality; Procalcitonin; Sepsis; Systemic inflammatory response syndrome (SIRS); Traumatic brain injury

Indexed keywords

EID: 84890009933     PISSN: None     EISSN: 14712253     Source Type: Journal    
DOI: 10.1186/1471-2253-13-48     Document Type: Article

References (33)

1. Rutland-Brown W, Langlois JA, Thomas KE, Xi YL. Incidence of traumatic brain injury in the United States, 2003. J Head Trauma Rehabil 2006, 21:544-548. 10.1097/00001199-200611000-00009, 17122685.
2. Selassie AW, Fakhry SM, Ford DW. Population-based study of the risk of in-hospital death after traumatic brain injury: the role of sepsis. J Trauma 2011, 71:1226-1234. 10.1097/TA.0b013e318226ecfc, 22071924.
3. Kourbeti IS, Papadakis JA, Neophytou C, Filippou M, Loannou A, Karabetsos DA, Bertsias G, Anastasaki M, Vakis AF. Infections in patients with traumatic brain injury who undergo neurosurgery. Br J Neurosurg 2011, 25:9-15. 10.3109/02688697.2010.500411, 20649406.
4. Kourbeti IS, Vakis AF, Papadakis JA, Karabetsos DA, Bertsias G, Filippou M, Ioannou A, Neophytou C, Anastasaki M, Samonis G. Infections in traumatic brain injury patients. Clin Microbiol Infect 2012, 18:359-364. 10.1111/j.1469-0691.2011.03625.x, 21851488.
5. Oconnor E, Venkatesh B, Mashongonyika C, Lipman J, Hall J, Thomas P. Serum procalcitonin and C-reactive protein as markers of sepsis and outcome in patients with neurotrauma and subarachnoid haemorrhage. Anaesth Intensive Care 2004, 32:465-470.
6. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G. SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2001, 2003(31):1250-1256.
7. Irwin AD, Carro ED. Procalcitonin. Arch Dis Child Educ Pract Ed 2011, 96:228-233. 10.1136/archdischild-2011-300178, 21992929.
8. Didebulidze K, Manjavidze N, Ubiria I, Gogberashvili K. Procalcitonin - marker of severe infection and sepsis. Georgian Med News 2007, 153:22-27.
9. Riedel S, Melendez JH, An AT, Rosenbaum JE, Zenilman JM. Procalcitonin as a marker for the detection of bacteremia and sepsis in the emergency department. Am J Clin Pathol 2011, 135:182-189. 10.1309/AJCP1MFYINQLECV2, 21228358.
10. Reinhart K, Meisner M. Biomarkers in the critically ill patient: procalcitonin. Crit Care Clin 2011, 27:253-263. 10.1016/j.ccc.2011.01.002, 21440200.
11. Sudhir U, Venkatachalaiah RK, Kumar TA, Rao MY, Kempegowda P. Significance of serum procalcitonin in sepsis. Indian J Crit Care Med 2011, 15:1-5. 10.4103/0972-5229.78214, 3097536, 21633539.
12. Schneider HG, Lam QT. Procalcitonin for the clinical laboratory: a review. Pathology 2007, 39:383-390. 10.1080/00313020701444564, 17676478.
13. Karlsson S, Heikkinen M, Pettila V, Alila S, Vaisanen S, Pulkki K, Kolho E, Ruokonen E. Predictive value of procalcitonin decrease in patients with severe sepsis: a prospective observational study. Crit Care 2010, 14:R205. 10.1186/cc9327, 3219988, 21078153.
14. Balci C, Sivaci R, Akbulut G, Karabekir HS. Procalcitonin levels as an early marker in patients with multiple trauma under intensive care. J Int Med Res 2009, 37:1709-1717. 10.1177/147323000903700606, 20146868.
15. Castelli GP, Pognani C, Cita M, Paladini R. Procalcitonin as a prognostic and diagnostic tool for septic complications after major trauma. Crit Care Med 2009, 37:1845-1849. 10.1097/CCM.0b013e31819ffd5b, 19384224.
16. Georgopoulou AP, Savva A, Giamarellos-Bourboulis EJ, Georgitsi M, Raftogiannis M. Early changes of procalcitonin may advise about prognosis and appropriateness of antimicrobial therapy in sepsis. J Crit Care 2011, 26:331.
17. Haasper C, Kalmbach M, Dikos GD, Meller R, Muller C, Krettek C, Hildebrand F, Frink M. Prognostic value of procalcitonin (PCT) and/or interleukin-6 (IL-6) plasma levels after multiple trauma for the development of multi organ dysfunction syndrome (MODS) or sepsis. Technol Health Care 2010, 18:89-100.
18. Seligman R, Meisner M, Lisboa TC, Hertz FT, Filippin TB, Fachel JM, Teixeira PJ. Decreases in procalcitonin and C-reactive protein are strong predictors of survival in ventilator-associated pneumonia. Crit Care 2006, 10:R125. 10.1186/cc5036, 1751074, 16956405.
19. Heyland DK, Johnson AP, Reynolds SC, Muscedere J. Procalcitonin for reduced antibiotic exposure in the critical care setting: A systematic review and an economic evaluation. Crit Care Med 2011, 39:1792-1799. 10.1097/CCM.0b013e31821201a5, 21358400.
20. De Wolf HK, Gunnewiek JK, Berk Y, van den Quweland J, De Metz M. Comparison of a new procalcitonin assay from roche with the established method on the brahms kryptor. Clin Chem 2009, 55:1043-1044. 10.1373/clinchem.2008.117655, 19264851.
21. Sauerland S, Hensler T, Bouillon B, Rixen D, Raum MR, Andermahr J, Neugebauer EA. Plasma level of procalcitonin and neopterin in multiple trauma patients with or without brain injury. J Neurotrauma 2003, 20:953-960. 10.1089/089771503770195803, 14588112.
22. Brain Trauma Foundation American Association of Neurological Surgeons: Congress of Neurological Surgeons: Guidelines for the management of severe traumatic brain injury. J Neurotrauma 2007, 24(Suppl 1):S1-S106. Brain Trauma Foundation.
23. Maas AI, Dearden M, Servadei F, Stocchetti N, Unterberg A. Current recommendations for neurotrauma. Curr Opin Crit Care 2000, 6:281-292. 10.1097/00075198-200008000-00008, 11329513.
24. Bratton SL, Chestnut RM, Ghajar J, McConnell, Hammond FF, Harris OA, Hartl R, Manley GT, Nemecek A, Newell DW. Guidelines for the management of severe traumatic brain injury. I. Blood pressure and oxygenation. J Neurotrauma 2007, 24(Suppl 1):S7-S13.
25. Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet 1974, 2:81-84.
26. Civil ID, Schwab CW. The Abbreviated Injury Scale, Revision: A Condensed Chart for clinical use. J Trauma 1985, 1988(28):87-90.
27. Nijsten MW, Olinga P, The TH, De Vries EG, Koops HS, Groothuis GM, Limburg PC, Ten, Duis HJ, Moshage H, Hoekstra HJ, Bijzet J, Zwaveling JH. Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med 2000, 28:458-461. 10.1097/00003246-200002000-00028, 10708183.
28. Wanner GA, Keel M, Steckholzer U, Beier W, Stocker R, Ertel W. Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients. Crit Care Med 2000, 28:950-957. 10.1097/00003246-200004000-00007, 10809265.
29. Maier M, Wutzler S, Lehnert M, Szermutzky M, Wyen H, Bingold T, Henrich D, Walcher F, Marzi I. Serum procalcitonin levels in patients with multiple injuries including visceral trauma. J Trauma 2009, 66:243-249. 10.1097/TA.0b013e31817c966f, 19131834.
30. Meisner M, Adina H, Schmidt J. Correlation of procalcitonin and C-reactive protein to imflammation, complications, and outcome during the intensive care unit course of multiple-trauma patients. Crit Care 2006, 10:R1. 10.1186/cc3910, 1550798, 16356205.
31. Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, Müller B. Effect of procalciton-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomized, single-blinded intervention trail. Lancet 2004, 363(9409):600-607. 10.1016/S0140-6736(04)15591-8, 14987884.
32. Christ-Crain M, Stolz D, Bingisser R, Müller C, Miedinger D, Huber PR, Zimmerli W, Harbarth S, Tamm M, Müller B. Procalciton-guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med 2006, 174(1):84-93. 10.1164/rccm.200512-1922OC, 16603606.
33. Marc E, Menager C, Moulin F, Stos B, Chalumeau M, Guerin S, Lebon P, Brunet F, Raymond J, Gendrel D. Procalcitonin and viral meningitis: reduction of unnecessary antibiotics by measurement during an outbreak. Arch Pediatr 2002, 9(4):358-364. 10.1016/S0929-693X(01)00793-X, 11998420.